Florida Cancer Specialists North Region Sarah Cannon Research
Saint Petersburg, Florida, United States
Research institute in Orlando, Florida
6400 Sanger Rd Suite A-1000, Orlando, FL 32827
About Florida Cancer Specialists North Region Sarah Cannon Research
"UCF Researchers in the Division of Cancer Research are on the vanguard of cancer biology."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
4
Elpiscience Biopharma, Ltd.
1
Shanghai HyaMab Biotech Co.,Ltd.
1
Clinical Trials at Florida Cancer Specialists North Region Sarah Cannon Research
During the past decade, Florida Cancer Specialists North Region Sarah Cannon Research conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma)
2013-11-21
2022-01-26
Completed
358
Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting
2014-05-29
2025-05-24
Active, not recruiting
186
A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve
2019-01-02
2027-09-28
Active, not recruiting
363
HY-0102 Monotherapy in Patients With Locally Advanced/Metastatic Solid Tumours
2022-05-03
2023-12-30
Recruiting
32
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
2022-06-23
2033-01-26
Recruiting
864
A Study of ES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors
2021-12-23
2023-12-01
Active, not recruiting
60
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Cancer Specialists North Region Sarah Cannon Research"
#1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Florida Cancer Specialists North Region Sarah Cannon Research
According to Clinical.Site data, the most researched conditions in "Florida Cancer Specialists North Region Sarah Cannon Research" are
"Multiple Myeloma" (2 trials), "Advanced Solid Tumor" (1 trials), "Locally Advanced/Metastatic Solid Tumors" (1 trials), "Lymphoma, Non-Hodgkin" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Florida Cancer Specialists North Region Sarah Cannon Research" in a lesser frequency.
Clinical Trials Intervention Types at Florida Cancer Specialists North Region Sarah Cannon Research
Most popular intervention types in "Florida Cancer Specialists North Region Sarah Cannon Research" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Daratumumab" (2 trials), "Dexamethasone" (2 trials), "Bortezomib" (1 trials), "Epoetin alfa" (1 trials) and "HY-0102" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Florida Cancer Specialists North Region Sarah Cannon Research
The vast majority of trials in "Florida Cancer Specialists North Region Sarah Cannon Research" are
6 trials for "All" genders.
Clinical Trials Status at Florida Cancer Specialists North Region Sarah Cannon Research
Currently, there are NaN active trials in "Florida Cancer Specialists North Region Sarah Cannon Research".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Florida Cancer Specialists North Region Sarah Cannon Research,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Florida Cancer Specialists North Region Sarah Cannon Research, 2 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".